Chemical Formula: C15H22N2O3

Chemical Formula C15H22N2O3

Found 62 metabolite its formula value is C15H22N2O3

Phenylalanylisoleucine

(2S,3S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylpentanoic acid

C15H22N2O3 (278.16303419999997)


Phenylalanylisoleucine is a dipeptide composed of phenylalanine and isoleucine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Leucylphenylalanine

(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-phenylpropanoic acid

C15H22N2O3 (278.1630342)


Leucylphenylalanine is a dipeptide composed of leucine and phenylalanine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. Leucyl-phenylalanine belongs to the class of organic compounds known as dipeptides.

   

Isoleucyl-Phenylalanine

2-[(2-Amino-1-hydroxy-3-methylpentylidene)amino]-3-phenylpropanoate

C15H22N2O3 (278.16303419999997)


Isoleucyl-Phenylalanine is a dipeptide composed of isoleucine and phenylalanine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

keratan sulfate I

4-[(3-butoxy-4-methoxyphenyl)methyl]-4,5-dihydro-3H-imidazol-2-ol

C15H22N2O3 (278.16303419999997)


keratan sulfate I, also known as Keratan sulfuric acid I or 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone, is classified as a member of the Anisoles. Anisoles are organic compounds containing a methoxybenzene or a derivative thereof. keratan sulfate I is considered to be practically insoluble (in water) and relatively neutral D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors

   

3-Methoxy-4-[2-(4-methylpiperazin-1-yl)ethoxy]benzaldehyde

3-Methoxy-4-[2-(4-methylpiperazin-1-yl)ethoxy]benzaldehyde

C15H22N2O3 (278.16303419999997)


   

Phenylalanylleucine

(2S)-2-[[(2S)-2-amino-3-phenylpropanoyl]amino]-4-methylpentanoic acid

C15H22N2O3 (278.16303419999997)


   

LF

2-[(2-Amino-1-hydroxy-4-methylpentylidene)amino]-3-phenylpropanoate

C15H22N2O3 (278.16303419999997)


Leucyl-phenylalanine, also known as (2s,3s)-(2-2h,3-2h)-leucine-(S)-phenylalanine or leu-phe, is a member of the class of compounds known as dipeptides. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Leucyl-phenylalanine is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Leucyl-phenylalanine can be found primarily in blood, feces, and urine. Leucyl-phenylalanine belongs to the class of organic compounds known as dipeptides.

   
   
   

4beta-Hydroxy-11-O-(2-pyrolylcarboxy)epilupinine

4beta-Hydroxy-11-O-(2-pyrolylcarboxy)epilupinine

C15H22N2O3 (278.16303419999997)


   

4beta-O-(2-Pyrrolylcarbonyl)epilupinine

4beta-O-(2-Pyrrolylcarbonyl)epilupinine

C15H22N2O3 (278.16303419999997)


   
   
   

Santacruzamate A

Carbamic acid, N-[4-oxo-4-[(2-phenylethyl)amino]butyl]-, ethyl ester

C15H22N2O3 (278.16303419999997)


Santacruzamate A is an organooxygen compound and an organonitrogen compound. It is functionally related to a gamma-amino acid. santacruzamate A is a natural product found in Cyanobacterium and Symploca with data available. D004791 - Enzyme Inhibitors > D056572 - Histone Deacetylase Inhibitors Santacruzamate A (CAY-10683) is a potent and selective HDAC2 inhibitor with an IC50 of 119 pM[1].

   

Tolycaine

Tolycaine

C15H22N2O3 (278.16303419999997)


C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent

   
   
   
   

11-O-(2-Pyrrolecarbonyl)-4-Hydroxyepilupinine

11-O-(2-Pyrrolecarbonyl)-4-Hydroxyepilupinine

C15H22N2O3 (278.16303419999997)


   

4-O-(2-Pyrrolecarbonyl)-4-Hydroxyepilupinine

4-O-(2-Pyrrolecarbonyl)-4-Hydroxyepilupinine

C15H22N2O3 (278.16303419999997)


   

Phenylalanylisoleucine (isomer of 1328)

Phenylalanylisoleucine (isomer of 1328)

C15H22N2O3 (278.16303419999997)


Annotation level-3

   

Leucylphenylalanine

Leucylphenylalanine

C15H22N2O3 (278.16303419999997)


Annotation level-2

   

Phenylalanylisoleucine (isomer of 1329)

Phenylalanylisoleucine (isomer of 1329)

C15H22N2O3 (278.16303419999997)


Annotation level-2

   

Ile-phe

2-(2-amino-3-phenylpropanamido)-3-methylpentanoic acid

C15H22N2O3 (278.16303419999997)


A dipeptide formed from L-isoleucine and L-phenylalanine residues.

   

Leu-phe

2-(2-amino-3-phenylpropanamido)-4-methylpentanoic acid

C15H22N2O3 (278.16303419999997)


A dipeptide formed from L-leucine and L-phenylalanine residues. Leucyl-phenylalanine belongs to the class of organic compounds known as dipeptides.

   

Phe-ile

2-(2-amino-3-methylpentanamido)-3-phenylpropanoic acid

C15H22N2O3 (278.16303419999997)


A dipeptide formed from L-phenylalanine and L-isoleucine residues.

   

tert-Butyl 3-(4-aminophenoxy)pyrrolidine-1-carboxylate

tert-Butyl 3-(4-aminophenoxy)pyrrolidine-1-carboxylate

C15H22N2O3 (278.16303419999997)


   

methyl 4-[[4-(2-hydroxyethyl)piperazin-1-yl]methyl]benzoate

methyl 4-[[4-(2-hydroxyethyl)piperazin-1-yl]methyl]benzoate

C15H22N2O3 (278.16303419999997)


   

2-methyl-3-nitro-N,N-dipropylbenzeneacetamide

2-methyl-3-nitro-N,N-dipropylbenzeneacetamide

C15H22N2O3 (278.16303419999997)


   

4-(Pyridin-4-yloxy)-piperidine-1-carboxylic acid tert-butyl ester

4-(Pyridin-4-yloxy)-piperidine-1-carboxylic acid tert-butyl ester

C15H22N2O3 (278.16303419999997)


   

tert-butyl 4-(4-hydroxyphenyl)piperazine-1-carboxylate

tert-butyl 4-(4-hydroxyphenyl)piperazine-1-carboxylate

C15H22N2O3 (278.16303419999997)


   

4-HYDROXY-3,4,5,6-TETRAHYDRO-2H-[2,4]BIPYRIDINYL-1-CARBOXYLIC ACID TERT-BUTYL ESTER

4-HYDROXY-3,4,5,6-TETRAHYDRO-2H-[2,4]BIPYRIDINYL-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C15H22N2O3 (278.16303419999997)


   

3-(4-HYDROXY-PHENYL)-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

3-(4-HYDROXY-PHENYL)-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C15H22N2O3 (278.16303419999997)


   

tert-butyl 7-(2-hydroxyethyl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxylate

tert-butyl 7-(2-hydroxyethyl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxylate

C15H22N2O3 (278.16303419999997)


   

Keratin Sulfate Sodium Salt,from Bovine Cornea

Keratin Sulfate Sodium Salt,from Bovine Cornea

C15H22N2O3 (278.16303419999997)


   

(2S,5R)-ethyl 5-(benzyloxyaMino)piperidine-2-carboxylate

(2S,5R)-ethyl 5-(benzyloxyaMino)piperidine-2-carboxylate

C15H22N2O3 (278.16303419999997)


   

3-(3-HYDROXY-PHENYL)-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

3-(3-HYDROXY-PHENYL)-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C15H22N2O3 (278.16303419999997)


   

1-(2-HYDROXY-PHENYL)-PIPERAZINE-4-CARBOXYLIC ACID TERT-BUTYL ESTER

1-(2-HYDROXY-PHENYL)-PIPERAZINE-4-CARBOXYLIC ACID TERT-BUTYL ESTER

C15H22N2O3 (278.16303419999997)


   

[1-(2-hydroxymethyl-phenyl)-azetidin-3-yl]-carbamic acid tert-butyl ester

[1-(2-hydroxymethyl-phenyl)-azetidin-3-yl]-carbamic acid tert-butyl ester

C15H22N2O3 (278.16303419999997)


   

tert-butyl 4-(3-hydroxyphenyl)piperazine-1-carboxylate

tert-butyl 4-(3-hydroxyphenyl)piperazine-1-carboxylate

C15H22N2O3 (278.16303419999997)


   
   
   

N-[4-(4-morpholinyl)phenyl]carbamic acid butyl ester

N-[4-(4-morpholinyl)phenyl]carbamic acid butyl ester

C15H22N2O3 (278.16303419999997)


   

(4r)-4-(3-Butoxy-4-Methoxybenzyl)imidazolidin-2-One

(4r)-4-(3-Butoxy-4-Methoxybenzyl)imidazolidin-2-One

C15H22N2O3 (278.16303419999997)


   

N,N-dimethyl-2-(5,6,7-trimethoxy-1H-indol-3-yl)ethanamine

N,N-dimethyl-2-(5,6,7-trimethoxy-1H-indol-3-yl)ethanamine

C15H22N2O3 (278.16303419999997)


   
   

N-butyl-N(2)-[(R)-2-hydroxy-2-phenylacetyl]-L-alaninamide

N-butyl-N(2)-[(R)-2-hydroxy-2-phenylacetyl]-L-alaninamide

C15H22N2O3 (278.16303419999997)


   

RO 20-1724

4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone

C15H22N2O3 (278.16303419999997)


D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors

   

phe-leu

phe-leu

C15H22N2O3 (278.16303419999997)


A dipeptide obtained by formal condensation of the carboxy group of L-phenylalanine with the amino group of L-leucine.

   

Phe-Leu zwitterion

Phe-Leu zwitterion

C15H22N2O3 (278.16303419999997)


A dipeptide zwitterion obtained by transfer of a proton from the carboxy to the amino terminus of Phe-Leu.

   

[(1s,2s,9ar)-2-hydroxy-octahydro-1h-quinolizin-1-yl]methyl 1h-pyrrole-2-carboxylate

[(1s,2s,9ar)-2-hydroxy-octahydro-1h-quinolizin-1-yl]methyl 1h-pyrrole-2-carboxylate

C15H22N2O3 (278.16303419999997)


   

(1r,2r,9s,10r,14s)-14-hydroxy-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecane-6,16-dione

(1r,2r,9s,10r,14s)-14-hydroxy-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecane-6,16-dione

C15H22N2O3 (278.16303419999997)


   

4-{[ethoxy(hydroxy)methylidene]amino}-n-(2-phenylethyl)butanimidic acid

4-{[ethoxy(hydroxy)methylidene]amino}-n-(2-phenylethyl)butanimidic acid

C15H22N2O3 (278.16303419999997)


   

(8e)-2-[(5e)-hept-5-en-1-yl]-8-(hydroxyimino)-3-methyl-6h,7h,8ah-pyrrolo[2,1-b][1,3]oxazin-4-one

(8e)-2-[(5e)-hept-5-en-1-yl]-8-(hydroxyimino)-3-methyl-6h,7h,8ah-pyrrolo[2,1-b][1,3]oxazin-4-one

C15H22N2O3 (278.16303419999997)


   

(5r)-5-hydroxy-1-methyl-3-methylidene-4-[(2e,4z)-7-methylocta-2,4-dienoyl]piperazin-2-one

(5r)-5-hydroxy-1-methyl-3-methylidene-4-[(2e,4z)-7-methylocta-2,4-dienoyl]piperazin-2-one

C15H22N2O3 (278.16303419999997)